229 related articles for article (PubMed ID: 9217183)
41. Diagnosis and management of primary nasal lymphoma of T-cell or NK-cell origin.
Liang R
Clin Lymphoma; 2000 Jun; 1(1):33-7; discussion 38. PubMed ID: 11707809
[TBL] [Abstract][Full Text] [Related]
42. Primary bony peripheral T-cell lymphoma mimicking nasal type NK/T-cell lymphoma: a case report.
Chuang SS; Lin CN; Li CY
Pathol Res Pract; 2002; 198(5):369-73. PubMed ID: 12092774
[TBL] [Abstract][Full Text] [Related]
43. Nasal natural killer/T-cell lymphoma and its association with type "i"/XhoI loss strain Epstein-Barr virus in Chile.
Cabrera ME; Eizuru Y; Itoh T; Koriyama C; Tashiro Y; Ding S; Rey S; Akiba S; Corvalan A
J Clin Pathol; 2007 Jun; 60(6):656-60. PubMed ID: 16775124
[TBL] [Abstract][Full Text] [Related]
44. [Prognostic predictors of nasal NK/T cell lymphoma detected by immunohistochemical staining].
Wang BY; Hong XN; Yin JL; Lu HF; Li XQ; Ma XJ; Guo Y
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):523-5. PubMed ID: 17147118
[TBL] [Abstract][Full Text] [Related]
45. NK-cell lymphoma with nodal presentation and expression of cutaneous lymphocyte-associated antigen.
Chang ST; Liao YL; Lin SH; Chuang SS
Pathol Res Pract; 2010 Jul; 206(7):463-6. PubMed ID: 19628338
[TBL] [Abstract][Full Text] [Related]
46. Extranodal natural killer/T-cell lymphoma, nasal type in Taiwan: a relatively higher frequency of T-cell lineage and poor survival for extranasal tumors.
Jhuang JY; Chang ST; Weng SF; Pan ST; Chu PY; Hsieh PP; Wei CH; Chou SC; Koo CL; Chen CJ; Hsu JD; Chuang SS
Hum Pathol; 2015 Feb; 46(2):313-21. PubMed ID: 25554090
[TBL] [Abstract][Full Text] [Related]
47. [Clinical analysis on 18 cases of primary nasal cavity and sinuses T/NK lymphomas].
Cui X; Liang C
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Nov; 18(11):651-2. PubMed ID: 15715405
[TBL] [Abstract][Full Text] [Related]
48. Therapeutic outcome of Epstein-Barr virus positive T/NK cell lymphoma in the upper aerodigestive tract.
Hahn JS; Lee ST; Min YH; Ko YW; Yang WI; Kim GE
Yonsei Med J; 2002 Apr; 43(2):175-82. PubMed ID: 11971211
[TBL] [Abstract][Full Text] [Related]
49. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.
Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P
Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738
[TBL] [Abstract][Full Text] [Related]
50. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients.
Cheung MM; Chan JK; Lau WH; Foo W; Chan PT; Ng CS; Ngan RK
J Clin Oncol; 1998 Jan; 16(1):70-7. PubMed ID: 9440725
[TBL] [Abstract][Full Text] [Related]
51. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
[TBL] [Abstract][Full Text] [Related]
52. Epstein-Barr virus-positive nodal T/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features.
Jeon YK; Kim JH; Sung JY; Han JH; Ko YH;
Hum Pathol; 2015 Jul; 46(7):981-90. PubMed ID: 25907865
[TBL] [Abstract][Full Text] [Related]
53. CD56-positive (nasal-type T/NK cell) lymphoma arising on the skin. Report of two cases and review of the literature.
Ansai S; Maeda K; Yamakawa M; Matsuda M; Saitoh S; Suwa S; Saitoh H; Ohtsuka M; Iwatsuki K
J Cutan Pathol; 1997 Sep; 24(8):468-76. PubMed ID: 9331892
[TBL] [Abstract][Full Text] [Related]
54. Diagnosis and management of extranodal NK/T cell lymphoma nasal type.
Tse E; Kwong YL
Expert Rev Hematol; 2016 Sep; 9(9):861-71. PubMed ID: 27347812
[TBL] [Abstract][Full Text] [Related]
55. Natural killer cell lymphoma in the duodenum.
Sumi M; Tauchi T; Sashida G; Kuriyama Y; Nakajima A; Mukai K; Ohyashiki K
Leuk Lymphoma; 2003 Jan; 44(1):201-4. PubMed ID: 12691165
[TBL] [Abstract][Full Text] [Related]
56. Clarification of CD3 immunoreactivity in nasal T/natural killer cell lymphomas: the neoplastic cells are often CD3 epsilon+.
Chan JK; Tsang WY; Ng CS
Blood; 1996 Jan; 87(2):839-41. PubMed ID: 8555511
[No Abstract] [Full Text] [Related]
57. Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma -- natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types.
Ohshima K; Liu Q; Koga T; Suzumiya J; Kikuchi M
Virchows Arch; 2002 Apr; 440(4):425-35. PubMed ID: 11956825
[TBL] [Abstract][Full Text] [Related]
58. [Study on the status of cell differentiation in nasal NK/T-cell lymphomas].
Jiang YM; Liu WP; Tang QL; Li GD; Guo J; Liao DY
Zhonghua Bing Li Xue Za Zhi; 2003 Oct; 32(5):437-9. PubMed ID: 14633456
[TBL] [Abstract][Full Text] [Related]
59. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624
[TBL] [Abstract][Full Text] [Related]
60. Challenge in diagnosis of CD56+ lymphoproliferative disorders: two cases of CD56+CD33+ lymphoma/leukemia.
Yang X; Wasserman PG; Bhargava A; Iqbal U; Ragnauth S; Fuchs A
Arch Pathol Lab Med; 2004 Aug; 128(8):e100-3. PubMed ID: 15270596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
